{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"85204d378ad4","filters":{"venue":"Revista de Osteoporosis y Metabolismo Mineral"}},"results":[{"id":"W4389690861","doi":"10.20960/revosteoporosmetabminer.00030","title":"Abaloparatida: el nuevo fármaco anabólico","year":2023,"lang":"es","type":"article","venue":"Revista de Osteoporosis y Metabolismo Mineral","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine","authors":[{"name":"Núria Guañabens","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02875724892741819,"gpt":0.354192566135632,"spread":0.3254353172082138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009985061,0.0004236656,0.001057516,0.001259908,0.0004315647,0.001909228,0.0006340535,0.001454305,0.009605723],"category_scores_gemma":[0.001369987,0.0001827935,0.0004345333,0.001023698,0.0008140591,0.001704842,0.0007421086,0.002599037,0.002800619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007688049,"about_ca_system_score_gemma":0.001653404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002587401,"about_ca_topic_score_gemma":0.004853236,"domain_scores_codex":[0.9996226,0.00009742236,0.00004595253,0.00008823151,0.0001097534,0.00003600154],"domain_scores_gemma":[0.9993826,0.0002437798,0.0001015733,0.00002940553,0.000164789,0.0000777747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008378598,0.0003000394,0.0009739618,0.00472236,0.0001331273,0.0004343496,0.0001638761,0.0001078368,0.004341469,0.01010772,0.04225131,0.935626],"study_design_scores_gemma":[0.0001245915,0.0003757472,0.001721724,0.001943436,0.0001520824,0.001317799,0.00009403432,0.00006460892,0.001442612,0.002854495,0.989888,0.00002080982],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002050155,0.9785218,0.000395432,0.01118753,0.002098053,0.00001533285,0.000137963,0.00003567885,0.00555812],"genre_scores_gemma":[0.01755144,0.9572701,0.001304656,0.006591932,0.003482648,0.0000387733,0.000267043,0.00002059156,0.01347273],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009605723,"threshold_uncertainty_score":0.03213441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}